IE
CRL icon

Israel Englander’s Charles River Laboratories CRL Stock Holding History

Israel Englander’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,900
Closed -$7.16M – 5818
2025
Q4 		$7.16M Buy
+35,900
New +$6.51M ﹤0.01% 2629
2025
Q3 		– Sell
-46,500
Closed -$7.06M – 6082
2025
Q2 		$7.06M Buy
+46,500
New +$6.2M ﹤0.01% 2624
2024
Q4 		– Sell
-10,600
Closed -$2.09M – 6029
2024
Q3 		$2.09M Sell
10,600
-20,600
-66% -$4.28M ﹤0.01% 3668
2024
Q2 		$6.45M Buy
31,200
+14,900
+91% +$3.38M ﹤0.01% 2483
2024
Q1 		$4.42M Buy
16,300
+6,300
+63% +$1.5M ﹤0.01% 2987
2023
Q4 		$2.36M Sell
10,000
-40,100
-80% -$7.89M ﹤0.01% 3475
2023
Q3 		$9.82M Buy
50,100
+26,800
+115% +$5.5M 0.01% 2072
2023
Q2 		$4.9M Buy
23,300
+13,300
+133% +$2.65M ﹤0.01% 2694
2023
Q1 		$2.02M Buy
+10,000
New +$2.27M ﹤0.01% 3432
2022
Q4 		– Sell
-32,400
Closed -$6.38M – 6631
2022
Q3 		$6.38M Sell
32,400
-2,600
-7% -$561K ﹤0.01% 2656
2022
Q2 		$7.49M Buy
35,000
+22,000
+169% +$5.38M ﹤0.01% 2364
2022
Q1 		$3.69M Buy
13,000
+10,000
+333% +$3.08M ﹤0.01% 3266
2021
Q4 		$1.13M Buy
+3,000
New +$1.17M ﹤0.01% 4302
2020
Q1 		– Sell
-135,000
Closed -$20.6M – 3941
2019
Q4 		$20.6M Buy
+135,000
New +$18.7M 0.03% 817
2019
Q1 		– Sell
-35,000
Closed -$3.96M – 4018
2018
Q4 		$3.96M Buy
+35,000
New +$4.38M 0.01% 1743
2018
Q2 		– Sell
-10,000
Closed -$1.07M – 3834
2018
Q1 		$1.07M Buy
+10,000
New +$1.08M ﹤0.01% 2653
2014
Q1 		– Sell
-5,000
Closed -$265K – 3504
2013
Q4 		$265K Buy
+5,000
New +$251K ﹤0.01% 3126

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Israel Englander's CRL Position: Q2 2026 in Review

Israel Englander reduced its Charles River Laboratories (CRL) stake by 48% in Q2 2026, selling an estimated $79.7M and leaving 486,462 shares worth $110M. The position accounts for 0.04% of the portfolio, ranked #469.

Israel Englander first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. The position peaked at $161M in Q1 2026. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Israel Englander held 486,462 shares of Charles River Laboratories worth $110M as of Q2 2026.
  • Israel Englander sold 447,583 Charles River Laboratories shares in Q2 2026, an estimated $79.7M.
  • Charles River Laboratories made up 0.04% of Israel Englander's portfolio in Q2 2026, its #469 holding.
  • Israel Englander first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Israel Englander's Charles River Laboratories position peaked at $161M in Q1 2026.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.